Personalized Breast Cancer Prevention Now Available for Women 30+ in the UK

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast cancer and take early action years before NHS screening begins.

The service delivers a personalised breast cancer prevention plan based on each woman’s genetic profile using a simple home saliva test and online clinical guidance. It is especially relevant for women under 50, who currently fall outside the national screening programme despite accounting for 1 in 5 breast cancer cases.

The service is organised and supported by a clinical consortium of experts from Prevent Breast Cancer, the Breast Awareness Clinic, Antegenes, and the University of Manchester.

"We need to do much more to prevent young women from getting breast cancer," said Lester Barr MBE, co-founder of Prevent Breast Cancer. “We also need to do more to empower women to understand their individual risk, so they can make informed choices about their health. Our goal is to see breast cancer risk assessments offered to all women over 30, paving the way for a risk-adapted screening programme. This would mean more frequent - and potentially earlier - screening for women identified as having an above-average risk, rather than just offering screening to all women over 50. While this approach is still several years away for the NHS, this independent website is already providing a valuable service that we hope will one day be available to everyone."

The service combines a clinically validated polygenic risk score (PRS) test with a short questionnaire to assess family history. Women with higher risk are offered clear recommendations for screening and prevention. PRS measures the cumulative effect of thousands of common genetic variants linked to breast cancer. The method helps identify at-risk women who may not have a family history or carry rare mutations that are traditionally tested for. Those with potential rare genetic mutations, like BRCA1 or BRCA2, are referred to appropriate NHS or private services for further specialised genetic testing.

"Polygenic risk scoring lets us assess risk earlier and more accurately," said Professor Gareth Evans, Consultant Geneticist and Professor of Medical Genetics at the University of Manchester. "Every woman should be offered this simple test from age 30."

The underlying test for this service was developed by health technology company Antegenes and is CE-marked, registered with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and validated using UK Biobank data.

While currently available as a private service, the team behind the initiative hopes it will contribute to a future NHS screening model that reflects women’s individual risk, beyond just age.

"We believe personalised approaches are a vital part of the future of cancer prevention and screening programmes," said Dr. Peeter Padrik, Oncologist and CEO of Antegenes.

"This service gives women something we've been missing for a long time - a chance to understand their breast cancer risk early and act on it in a way that fits their life," said Laura Naylor, Director of the Breast Awareness Clinic. "It's simple, supportive, and backed by real clinical evidence - exactly what we need to make personalised prevention part of everyday care."

The group members also recently published the first clinical guidelines for using PRS in breast cancer in the journal Cancers, offering a roadmap for integrating this innovation into routine healthcare.

Padrik P, Tõnisson N, Hovda T, Sahlberg KK, Hovig E, Costa L, Nogueira da Costa G, Feldman I, Sampaio F, Pajusalu S, Ojamaa K, Kallak K, Tihamäe AT, Roht L, Kahre T, Lepland A, Sõber S, Kruuv-Käo K, Tamm M, Varghese J, Evans DG; AnteNOR and BRIGHT Research Consortia.
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores.
Cancers (Basel). 2025 Mar 21;17(7):1056. doi: 10.3390/cancers17071056

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Mayo Clinic's AI Tool Identifies 9 …

Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single...

AI Detects Fatty Liver Disease with Ches…

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...